{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:15:37Z","timestamp":1791281737279,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004452.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T00:00:00Z","timestamp":1402012800000}}],"reference-count":97,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004452.pub3","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T01:12:09Z","timestamp":1402017129000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Oxytocin receptor antagonists for inhibiting preterm labour"],"prefix":"10.1002","volume":"2014","author":[{"given":"Vicki","family":"Flenady","sequence":"first","affiliation":[{"name":"Mater Research Institute - The University of Queensland (MRI-UQ); Translating Research Into Practice (TRIP) Centre; Level 2 Aubigny Place, Mater Health Services Annerley Road, Woolloongabba Brisbane Queensland Australia 4102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna E","family":"Reinebrant","sequence":"additional","affiliation":[{"name":"Mater Research Institute - The University of Queensland (MRI-UQ); Translating Research Into Practice (TRIP) Centre; Level 2 Aubigny Place, Mater Health Services Annerley Road, Woolloongabba Brisbane Queensland Australia 4102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen G","family":"Liley","sequence":"additional","affiliation":[{"name":"Mater Mothers\u2019 Hospital, Mater Research, The University of Queensland; South Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eashan G","family":"Tambimuttu","sequence":"additional","affiliation":[{"name":"Royal Brisbane and Women's Hospital; Department of Gynaecology Oncology\/Obstetrics and Gynaecology; Butterfield Street, Herston Brisbane Queensland Australia 4006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri NM","family":"Papatsonis","sequence":"additional","affiliation":[{"name":"Amphia Hospital Breda; Department of Obstetrics and Gynaecology; Langendijk 75 Breda Netherlands 4819 EV"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,6,6]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD004452.pub3-BIB0001|cit1","first-page":"87","article-title":"Atosiban as a tocolytic agent: a new proposal of a therapeutic approach","volume":"30","author":"Cabar","year":"2008","journal-title":"Revista Brasileira de Ginecologia y Obstetricia"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1034\/j.1600-0412.2001.d01-456.x","article-title":"The oxytocin antagonist atosiban versus the \u00df-agonist terbutaline in the treatment of preterm labor: a randomized, double-blind, controlled study","volume":"80","author":"The European Atosiban Study Group","year":"2001","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-0528.2001.00043.x","article-title":"Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour","volume":"108","author":"The Worldwide Atosiban versus Beta-antagonists Study Group","year":"2001","journal-title":"BJOG"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0301-2115(01)00331-1","article-title":"Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol","volume":"98","author":"French\/Australian Atosiban Investigators Group","year":"2001","journal-title":"European Journal Obstetrics, Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-0528.2001.00043.x","article-title":"Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour","volume":"108","author":"The Worldwide Atosiban versus Beta-antagonists Study Group","year":"2001","journal-title":"BJOG"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0002-9378(94)70214-4","article-title":"The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human","volume":"170","author":"Goodwin","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9378(12)91463-5","article-title":"Safety and efficacy of the oxytocin antagonist atosiban in threatened preterm labor: initial US trial","volume":"166","author":"Goodwin","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD004452.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-994312","article-title":"Treatment of preterm labor with the oxytocin antagonist atosiban","volume":"13","author":"Goodwin","year":"1996","journal-title":"American Journal of Perinatology"},{"issue":"3","key":"10.1002\/14651858.CD004452.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0029-7844(96)00200-1","article-title":"Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor","volume":"88","author":"Goodwin","year":"1996","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD004452.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijgo.2005.06.005","article-title":"Atosiban and nifedipin for the treatment of preterm labor","volume":"91","author":"Kashanian","year":"2005","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"s1","key":"10.1002\/14651858.CD004452.pub3-BIB0011|cit11","first-page":"69","article-title":"Atosiban and nifedipin for the treatment of preterm labor","volume":"115","author":"Kashanian","year":"2008","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD004452.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0929-6646(09)60097-8","article-title":"Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists\u00a0 in the treatment of spontaneous preterm labor in Taiwanese women","volume":"108","author":"Lin","year":"2009","journal-title":"Journal of the Formosan Medical Association = Taiwan Yi Zhi"},{"issue":"167","key":"10.1002\/14651858.CD004452.pub3-BIB0013|cit13","first-page":"33","article-title":"Comparison of atosiban versus ritodrine in the treatment of pre-term labour","volume":"76","author":"Moutquin","year":"1997","journal-title":"Acta Obstetrica et Gynecologica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD004452.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1067\/mob.2000.104950","article-title":"Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study","volume":"182","author":"Moutquin","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD004452.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0029-1225640","article-title":"Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour","volume":"213","author":"Nonnenmacher","year":"2009","journal-title":"Zeitschrift fur Geburtshilfe und Neonatologie"},{"issue":"1","key":"10.1002\/14651858.CD004452.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00404-004-0652-8","article-title":"Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy","volume":"272","author":"Richter","year":"2005","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0019|cit17","unstructured":"Goodwin TM 1st International preterm labour congress. Strategies to prevent the morbidity and mortality associated with prematurity; 2002 June 27-30. Le Montreux Palace, Montreux Switzerland 2002"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0020|cit18","unstructured":"Goodwin TM Long-term safety with oxytocin antagonists 4th World Congress on Controversies in Obstetrics, Gynecology and Infertility; 2003 April 24-27; Berlin, Germany 2003 291"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0017|cit19","unstructured":"Goodwin TM Randall H Perry K Menard MK Bauer C Shangold G A report on infant outcomes at 6 and 12 months after the use of atosiban in the management of preterm labor 46th ACOG Annual Meeting; 1998 May 9-13; New Orleans, Louisiana 1998"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0018|cit20","unstructured":"Goodwin TM Randall H Perry K Menard MK Bauer C Shangold G A report on infant outcomes up to 24 months after the use of atosiban in the management of preterm labor 46th ACOG Annual Meeting; 1998 May 9-13; New Orleans, Louisiana 1998"},{"issue":"5","key":"10.1002\/14651858.CD004452.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/mob.2000.95834","article-title":"An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue","volume":"182","author":"Romero","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD004452.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0002-9378(97)80072-5","article-title":"A double-blind placebo-controlled trial of an oxytocin-receptor antagonist (antocin) in the treatment of preterm labor","volume":"176","author":"Sibai","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD004452.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0002-9378(97)80193-7","article-title":"Maternal side effects and safety of the oxytocin receptor antagonist antocin","volume":"176","author":"Silver","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0024|cit24","unstructured":"Garmi G Nifedipine compared to atosiban for treating preterm labor accessed 9 April 2008"},{"issue":"6","key":"10.1002\/14651858.CD004452.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/AOG.0b013e3182755dff","article-title":"Nifedipine compared with atosiban for treating preterm labor: A randomized controlled trial","volume":"120","author":"Salim","year":"2012","journal-title":"Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD004452.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1471-0528.2006.01053.x","article-title":"Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women","volume":"113","author":"Shim","year":"2006","journal-title":"BJOG"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0027|cit27","unstructured":"Arce JC A proof of concept study assessing the effect of four different stage bolus intravenous doses of FE200440 and placebo on stopping preterm labor (ongoing trial) ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0028|cit28","unstructured":"Thornton S Goodwin TM Greisen G Hedegaard M Arce JC The effect of a selective oxytocin antagonist (barusiban) in threatened preterm labour: a randomized, double-blind, placebo-controlled trial 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 129"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004452.pub3-BIB0029|cit29","first-page":"Fa11","article-title":"The effect of barusiban on plasma concentrations and uterine contractility in threatened preterm labour: a randomised, double-blind, placebo-controlled trial","volume":"93","author":"Thornton","year":"2008","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"6","key":"10.1002\/14651858.CD004452.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"627.e1","DOI":"10.1016\/j.ajog.2009.01.015","article-title":"The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial","volume":"200","author":"Thornton","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1-2","key":"10.1002\/14651858.CD004452.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2005.12.010","article-title":"Atosiban and nifedipine in acute tocolysis: a comparative study","volume":"128","author":"Al-Omari","year":"2006","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0032|cit32","unstructured":"Al-Omari WR Al-Tikri E Al-Shammaa H Atosiban and nifedipine in acute tocolysis, comparative study XVIIIth European Congress of Obstetrics and Gynaecology; May 12-15; Athens, Greece 2004 103"},{"issue":"2","key":"10.1002\/14651858.CD004452.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejogrb.2008.01.001","article-title":"A prospective randomized trial of acute tocolysis in term labour with atosiban or ritodrine","volume":"139","author":"Heus","year":"2008","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD004452.pub3-BIB0034|cit34","first-page":"S181","article-title":"An economic analysis of atosiban maintenance therapy in preterm labor","volume":"178","author":"Gagnon","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0035|cit35","unstructured":"Anonymous TREASURE (Tractocile efficacy assessment survey in Europe). Trial to commence in July http:\/\/www.ferring.com\/"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004452.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1471-0528.2003.00041.x-i1","article-title":"Clinical practice evaluation of atosiban in preterm labour management in six European countries","volume":"113","author":"Husslein","year":"2006","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD004452.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1515\/JPM.2007.078","article-title":"Atosiban versus usual care for the management of preterm labor","volume":"35","author":"Husslein","year":"2007","journal-title":"Journal of Perinatal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004452.pub3-BIB0038|cit38","first-page":"61","article-title":"Prevention of preterm delivery in twin pregnancies with atosiban","volume":"22","author":"Poppiti","year":"2009","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004452.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09513590400021144","article-title":"The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor","volume":"20","author":"Steinwall","year":"2005","journal-title":"Gynecological Endocrinology"},{"issue":"167","key":"10.1002\/14651858.CD004452.pub3-BIB0040|cit40","first-page":"88","article-title":"Estradiol levels are increased before and after preterm labor treatment with an oxytocin (OT) antagonist: evidence for chronic activation of the mechanism of labor","volume":"76","author":"Valenzuela","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD004452.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0002-9378(97)80139-1","article-title":"A double-blind placebo-controlled trial of oxytocin receptor antagonist (antocin) maintenance therapy in patients with preterm labor","volume":"176","author":"Sanchez-Ramos","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD004452.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1067\/mob.2000.105816","article-title":"Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The atosiban ptl-098 study group","volume":"182","author":"Valenzuela","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD004452.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14767050802702349","article-title":"The effects of the tocolytics atosiban and nifedipine on fetal movements, heart rate and blood flow","volume":"22","author":"Heus","year":"2009","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004452.pub3-BIB0044|cit44","first-page":"S197","article-title":"Atosiban versus fenoterol treatment of pre-term labour: randomised, prospective, multicentre study","volume":"286","author":"Lenzen","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0045|cit45","first-page":"22","article-title":"Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine","volume":"21(Suppl 1)","author":"Neri","year":"2008","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004452.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-0028-1103153","article-title":"Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine","volume":"26","author":"Neri","year":"2009","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0047|cit47","unstructured":"Renzo DGC Mignosa MM Rosati A Burnelli L Epicoco G Luzi G Can we effectively arrest premature labour in women with multiple gestations or other high-risk factors? 4th World Congress on Controversies in Obstetrics, Gynecology & Infertility; 2003 April 24-27; Berlin, Germany 2003 286 90"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0048|cit48","unstructured":"Anonymous The safety, tolerability and metabolism of GSK221149A, in pregnant women (34-36 weeks), in preterm labor ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD004452.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ajog.2012.10.515","article-title":"A multicenter, randomized, double-blind, placebo-controlled phase 2 trial of retosiban, a selective oxytocin receptor antagonist, for the management of preterm labor","volume":"208","author":"Snidow","year":"2013","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0050|cit50","unstructured":"Heida K Nifedipine versus Atosiban in the treatment of threatened preterm labour: APOSTEL III http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=2947"},{"issue":"10","key":"10.1002\/14651858.CD004452.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1471-0528.1999.tb08112.x","article-title":"Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women","volume":"106","author":"Akerlund","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD004452.pub3-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004352.pub2","article-title":"Betamimetics for inhibiting preterm labour","author":"Anotayanonth","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9832","key":"10.1002\/14651858.CD004452.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/9783527648207.ch10","article-title":"Retosiban and epelsiban: potent and selective orally available oxytocin antagonists","volume-title":"Protein-Protein Interactions in Drug Discovery","author":"Borthwick","year":"2013"},{"issue":"9862","key":"10.1002\/14651858.CD004452.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(12)61856-X","article-title":"Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index","volume":"381","author":"Chang","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0056|cit56","first-page":"1045","article-title":"Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials","volume":"110","author":"Coomarasamy","year":"2003","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD004452.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000065.pub2","article-title":"Prophylactic corticosteroids for preterm birth","author":"Crowley","year":"1996","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004452.pub3-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001060","article-title":"Magnesium sulphate for preventing preterm birth in threatened preterm labour","author":"Crowther","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004452.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"F80","DOI":"10.1136\/adc.2007.115816","article-title":"Value and validity of neonatal disease severity scoring systems","volume":"93","author":"Dorling","year":"2008","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"1","key":"10.1002\/14651858.CD004452.pub3-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004661.pub3","article-title":"Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus","author":"Doyle","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004452.pub3-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002860","article-title":"Nitric oxide donors for the treatment of preterm labour","author":"Duckitt","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0062|cit62","unstructured":"Advisory Committee for Reproductive Health Drugs Issue-NDA 20-797 Antocin, (atosiban injection) for use in the management of preterm labor Centre for Drug Evaluation and Research, Food and Drug Administration. Gaithersburg, Maryland April 20 1998 83 5"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0063|cit63","unstructured":"Advisory Committee for Reproductive Health Drugs Issue-NDA 20-797 Antocin, (atosiban injection) for use in the management of preterm labor Centre for Drug Evaluation and Research, Food and Drug Administration. Gaithersburg, Maryland April 20 1998 81"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0064|cit64","unstructured":"U.S. Food Drug Administration Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm243539.htm"},{"issue":"3","key":"10.1002\/14651858.CD004452.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1471-0528.2004.00059.x","article-title":"How should randomised trials including multiple pregnancies be analysed?","volume":"111","author":"Gates","year":"2004","journal-title":"BJOG"},{"issue":"9606","key":"10.1002\/14651858.CD004452.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004452.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-994312","article-title":"Treatment of preterm labor with the oxytocin antagonist atosiban","volume":"13","author":"Goodwin","year":"1996","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0068|cit68","unstructured":"Goodwin TM Randall H Perry K Menard MK Bauer C Shangold G A report on infant outcomes up to 24 months of age after the use of atosiban in the management of preterm labour 46th ACOG annual meeting; 1998 May 9-13; New Orleans, Louisiana 1998"},{"issue":"4","key":"10.1002\/14651858.CD004452.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0095-5108(18)30087-3","article-title":"Oxytocin receptor antagonists. Update","volume":"25","author":"Goodwin","year":"1998","journal-title":"Clinics in Perinatology"},{"issue":"5","key":"10.1002\/14651858.CD004452.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0029-7844(99)00329-4","article-title":"Tocolysis for preterm labor: a systematic review","volume":"94","author":"Gyetvai","year":"1999","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e6226","DOI":"10.1136\/bmj.e6226","article-title":"Tocolytic therapy for preterm delivery: systematic review and network meta-analysis","volume":"345","author":"Haas","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0073|cit73","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD004452.pub3-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007748.pub2","article-title":"Cyclo-oxygenase (COX) inhibitors for preventing preterm labour","author":"Khanprakob","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1471-0528.1988.tb06860.x","article-title":"Beta-mimetics in preterm labour: an overview of the randomized controlled trials","volume":"95","author":"King","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD004452.pub3-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002255","article-title":"Calcium channel blockers for inhibiting preterm labour","author":"King","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004452.pub3-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001992.pub2","article-title":"Cyclo-oxygenase (COX) inhibitors for treating preterm labour","author":"King","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004452.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0301-2115(97)00255-8","article-title":"A randomized comparison of nifedipine and ritodrine for suppression of preterm labor","volume":"77","author":"Koks","year":"1998","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"9","key":"10.1002\/14651858.CD004452.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.2010.1226","article-title":"Perinatal regionalization for very low-birth-weight and very preterm infants: a meta-analysis","volume":"304","author":"Lasswell","year":"2013","journal-title":"JAMA"},{"issue":"9832","key":"10.1002\/14651858.CD004452.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0081|cit81","first-page":"155","article-title":"Development of an oxytocin antagonist atosiban","volume":"16","author":"Melin","year":"1994","journal-title":"Research Clinical Forums"},{"issue":"11","key":"10.1002\/14651858.CD004452.pub3-BIB0082|cit82","first-page":"1025","article-title":"FE 200 440: a selective oxytocin antagonist on the term-pregnant human uterus","volume":"110","author":"Nilsson","year":"2003","journal-title":"BJOG"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0083|cit83","first-page":"296","article-title":"Nifedipine in the management of preterm labour: evidence from the literature","volume-title":"Preterm Birth","author":"Papatsonis","year":"2004"},{"issue":"3","key":"10.1002\/14651858.CD004452.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"F225","DOI":"10.1136\/adc.2009.161117","article-title":"A structured review of the recent literature on the economic consequences of preterm birth","volume":"96","author":"Petrou","year":"2011","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/07853890701806181","article-title":"Genetic contributions to preterm birth: implications from epidemiological and genetic association studies","volume":"40","author":"Plunkett","year":"2008","journal-title":"Annals of Medicine"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0086|cit86","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"3","key":"10.1002\/14651858.CD004452.pub3-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004454.pub2","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","author":"Roberts","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004452.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"e54992","DOI":"10.1371\/journal.pone.0054992","article-title":"Rethinking stress in parents of preterm infants: a meta-analysis","volume":"8","author":"Schappin","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jech.45.2.89","article-title":"The potential and limitations of meta-analysis","volume":"45","author":"Spector","year":"1991","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"1","key":"10.1002\/14651858.CD004452.pub3-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006770.pub2","article-title":"Progestational agents for treating threatened or established preterm labour","author":"Su","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00003495-200464040-00003","article-title":"Atosiban for preterm labour","volume":"64","author":"Tsatsaris","year":"2004","journal-title":"Drugs"},{"issue":"7467","key":"10.1002\/14651858.CD004452.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/bmj.329.7467.675","article-title":"Epidemiology of preterm birth","volume":"329","author":"Tucker","year":"2004","journal-title":"BMJ."},{"key":"10.1002\/14651858.CD004452.pub3-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"350546","DOI":"10.1155\/2011\/350546","article-title":"The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents","volume":"2011","author":"Vrachnis","year":"2011","journal-title":"International Journal of Endocrinology"},{"key":"10.1002\/14651858.CD004452.pub3-BIB0094|cit94","volume-title":"Born Too Soon: The Global Action Report on Preterm Birth","author":"Howson","year":"2012"},{"issue":"3","key":"10.1002\/14651858.CD004452.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-3016.2011.01196.x","article-title":"Analysis of binary outcomes from randomised trials including multiple births: when should clustering be taken into account?","volume":"25","author":"Yelland","year":"2011","journal-title":"Paediatric and Perinatal Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004452.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"e936","DOI":"10.1542\/peds.2007-1620","article-title":"Differences in rates and short-term outcome of live births before 32 weeks of gestation in Europe in 2003: results from the MOSAIC cohort","volume":"121","author":"Zeitlin","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD004452.pub3-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004452.pub2","article-title":"Oxytocin receptor antagonists for inhibiting preterm labour","author":"Papatsonis","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004452.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T14:37:32Z","timestamp":1715351852000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004452.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,6]]},"references-count":97,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004452.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,6]]}}}